Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Non-human primate models of multiple sclerosis.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran.
Interferon alpha association with neuromyelitis optica.
The Chalder Fatigue Questionnaire is a valid and reliable measure of perceived fatigue severity in multiple sclerosis.
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
[Experience in the use of high-frequency selective percutaneous rhizotomy in trigeminal neuralgia associated with multiple sclerosis].
Purinergic Signaling and the Functioning of the Nervous System Cells.
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders.
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
Multifocal VEP assessment of optic neuritis evolution.
A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate.
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
Vaccination-induced bilateral optic neuritis: rare but existing.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
Sunlight exposure and multiple sclerosis in a tropical country.
MS patients must have access to the best treatment options.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
Pages
« first
‹ previous
…
527
528
529
530
531
532
533
534
535
…
next ›
last »